Form D · Biotechnology

Tmunity Therapeutics, Inc.

Philadelphia, PA · CIK 0001661702

Offering snapshot reported Oct 30, 2019 · SEC filing

Reported sold
$75M
Offering amount: $75M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 22, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2019Initial$74,999,948No comparison7SEC filing
May 8, 2018Amendment$84,999,979$34,999,980vs Feb 6, 20185SEC filing
Feb 6, 2018Initial$49,999,999No comparison3SEC filing
Jan 3, 2018Initial$4,999,998No comparison1SEC filing
Feb 5, 2016Initial$5,000,000No comparison2SEC filing
Dec 22, 2015Initial$5,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-352200

Source: Form D, filed Oct 30, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Usman Azam Director, Executive
Graeme Bell Executive
Anne Chew Director
Michael Christiano Executive
Christina Coughlin Executive
Patrick Gray Director
Moji James Executive
Jason Krentz Executive
Judith Li Director
Kevin Mahoney Director
Garry Nicholson Director
Sean Parker Director
Alessandro Riva Director
Beth Seidenberg Director
Yan Zhang Director
Jiang Zhang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3020 Market Street Suite 535
Philadelphia, PA, 19104